TXG · 10x Genomics Inc
United States · RS rating 88 · As of 2026-11-03
| Price | 65.29 USD |
|---|---|
| 1-day change | +5.9% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 10 / 94 / 98 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 46 / 56 / 50 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +40.9% |
| Sales growth Q/Q | +11.4% |
| Distance from 52-week high | +33.2% |
| Market cap (USD) | $2.7B |